AC Immune (ACIU) Shares Outstanding (Diluted Average) (2015 - 2019)

AC Immune (ACIU) has 4 years of Shares Outstanding (Diluted Average) data on file, last reported at $933.76 in Q3 2019.

• Quarterly Shares Outstanding (Diluted Average) changed N/A year-over-year to $933.76 in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $933.76 (changed N/A YoY) and the FY2017 annual result came in at $57.9 million, up 15.49% from the prior year.
• Shares Outstanding (Diluted Average) advanced to $933.76 in Q3 2019 per ACIU's latest filing, from $668.2 in the prior quarter.
• Across five years, Shares Outstanding (Diluted Average) topped out at $257.7 million in Q2 2016 and bottomed at $668.2 in Q2 2019.
• The 4-year median for Shares Outstanding (Diluted Average) is $48.3 million (2015), against an average of $68.7 million.
• The widest annual swing landed in 2016, when Shares Outstanding (Diluted Average) increased 7.67%; it then gained 15.49% in 2017.
• Tracing ACIU's Shares Outstanding (Diluted Average) over 4 years: stood at $46.5 million in 2015, then rose by 7.67% to $50.1 million in 2016, then advanced by 15.49% to $57.9 million in 2017, then tumbled by 100.0% to $933.76 in 2019.
• Per Business Quant, the three latest ACIU Shares Outstanding (Diluted Average) figures stand at $933.76 (Q3 2019), $668.2 (Q2 2019), and $57.9 million (Q4 2017).

Peer Comparison